Old Web
English
Sign In
Acemap
>
authorDetail
>
Andreas M. Passam
Andreas M. Passam
Bone marrow
Medicine
Diabetes mellitus
Tumor necrosis factor alpha
Myelodysplastic syndromes
4
Papers
62
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The assessment of proliferating cell nuclear antigen immunostaining in myelodysplastic syndromes and its prognostic significance.
2009
European Journal of Histochemistry
Michael G. Alexandrakis
Freda Passam
Konstantina Dambaki
Andreas M. Passam
Nalbanti F
Stathopoulos Es
Kyriakou Ds
Show All
Source
Cite
Save
Citations (6)
Systemic levels of matrix metalloproteinase-9 in patients with multiple myeloma may be useful as a prognostic index of bone disease. Reply to the Letter by Demacq and Montenegro
2006
Clinical Chemistry and Laboratory Medicine
Aikaterini Sfiridaki
Spiros Miyakis
George Tsirakis
Athanassios Alegakis
Andreas M. Passam
Ermioni Kandidaki
Andrew N. Margioris
Michael G. Alexandrakis
Show All
Source
Cite
Save
Citations (0)
Serum Evaluation of Angiogenic Cytokines Basic Fibroblast Growth Factor, Hepatocyte Growth Factor and TNF-ALPHA in Patients with Myelodysplastic Syndromes: Correlation with Bone Marrow Microvascular Density:
2005
International Journal of Immunopathology and Pharmacology
Michael G. Alexandrakis
Freda Passam
Constantina A. Pappa
John Damilakis
George Tsirakis
Ermioni Kandidaki
Andreas M. Passam
Efstathios N. Stathopoulos
D.S. Kyriakou
Show All
Source
Cite
Save
Citations (36)
Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease
2005
Clinical Chemistry and Laboratory Medicine
Aikaterini Sfiridaki
Spiros Miyakis
George Tsirakis
Athanassios Alegakis
Andreas M. Passam
Ermioni Kandidaki
Andrew N. Margioris
Michael G. Alexandrakis
Show All
Source
Cite
Save
Citations (20)
1